13.07.2015 Views

Official Proceedings - AIUM

Official Proceedings - AIUM

Official Proceedings - AIUM

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

American Institute of Ultrasound in Medicine <strong>Proceedings</strong> J Ultrasound Med 32(suppl):S1–S134, 2013ever, there is a need to improve standards of practice and interpretation aswell as to standardize terminology.Methods—A steering committee commissioned experiencedEuropean users to submit sections of guidelines along the lines of thosepreviously published for contrast-enhanced ultrasound.1,2 An introductorysection on the basic principles was followed by sections coveringparts of the body in which elastography is widely used, including the liver,the breast, endoscopic uses, the bowel, the prostate, the thyroid, and themusculoskeletal system.Results—The basic principles section aims to improve understandingof clinical elastography by synthesizing the underlying principlesof the 2 most commonly used forms: strain and shear waveelastography. Each clinical section contains a survey of the literature,especially where there are meta-analyses, and practical advice on theperformance and interpretation of elasticity examinations. The editeddocument is to be submitted to the European Journal of Ultrasound (Ultraschallin der Medizin) with a target date of January 2013.Conclusions—It is hoped that the European Federation of Societiesfor Ultrasound in Medicine and Biology (EFSUMB) guidelines onelastography will be as useful as the contrast-enhanced ultrasound guidelinesin improving understanding and clinical practice. The contributions ofthe EFSUMB Elastography Guidelines Team are gratefully acknowledged.References1. Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinicalpractice recommendations for contrast-enhanced ultrasound(CEUS): update 2008. Ultraschall Med 2008; 29:28–44.2. Piscaglia F, Nolsoe C, Dietrich CF, et al. The EFSUMB guidelines andrecommendations on the clinical practice of contrast-enhanced ultrasound(CEUS): update 2011 on nonhepatic applications. UltraschallMed 2012; 33:33–59.1540689 Implementation of Bedside Ultrasonography Within anInternal Medicine Faculty and Residency: The IMBUSProgramDavid Tierney,* Terry Rosborough Medical Education,Abbott Northwestern Hospital, Minneapolis, Minnesota USAObjectives—Describe in detail and provide a rationale for acurriculum, structure, and successful implementation of an internal medicinebedside ultrasound (IMBUS) program in a residency program andits faculty.Methods—Design: Prospective cohort study in an internalmedicine (IM) residency program at a private academic 700-bed tertiarycare center. Participants: 33 residents and 13 full-time faculty memberswithout significant prior ultrasound experience. Intervention: (1) Developmentof an IM ultrasound curriculum to maximize sensitivity/specificityof our routine physical exam as well as critical time sensitivediagnoses; (2) overlap training method using top-down and bottom-upmethodologies; (3) 35-hour “boot camp” including didactic, hands-onmodel-based, and simulator-based training; (4) bedside hands-on trainingwith faculty mentors until the trainee meets a prespecified exam count ineach component and is deemed competent in that exam area; (5) ongoingmentored and remotely submitted/reviewed images until adequate technicaland interpretive sensitivity/specificity are obtained; (6) final test-outusing bedside and simulator-based summative evaluation prior to certification;and (7) a robust ongoing quality assurance system. Measurements:Comparative effectiveness of multiple implementation strategies; time to,variation in, and predictive factors of competence in each exam component;clinical impact of chosen components on patient outcomes; and effectof implementation on resident/faculty work flow, efficiency, and jobsatisfaction.Results—We describe in detail and rigorously critique a full ultrasoundcurriculum and implementation strategy for an IM residency.Thirty IM residents and 12 faculty members were trained using theIMBUS program. Learning curves for each ultrasound exam componenthave been established. We are analyzing multiple outcomes, includingcompetency learning curves, skill decay, patient outcomes and experience,and physician impact of bedside ultrasound.Conclusions—We hope that by describing in detail our curriculum,methods, and learning, we can help other residency programsimplement bedside ultrasound in an efficient, focused, evidence-based,politically aware, and impactful manner.1506540 Prostate Cancer Responses to Testosterone and GrowthHormoneRobert Bard Biofoundation, New York, New York USAObjectives—Hypogonadal patients with low-grade prostatecancer are now treated with testosterone +/– growth hormone. It has beenestablished that high vascular density indicates a high-grade tumor. Ourstudy was to observe Doppler sonographic vessel density imaging inknown cancer sites to predict aggressive changes and arrest testosteroneand or growth hormone supplementation.Methods—Sixty-three patients treated with testosterone havinglow-grade (Gleason 6) disease were followed over a 3-year period.The vessel index was assessed on sonography by 3D histogram analysisand by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Follow-up biopsies were obtained shortly after imaging studies,which occurred at 6-month intervals for 3 years on patients with prostatespecificantigen (PSA) rises. Nineteen of 63 patients were concomitantlytaking growth hormone formulations.Results—Forty-one of 63 testosterone patients had no increasein PSA or neovascularity at 6, 12, 24, and 36 months. Three of 63 patientshad increased PSA and vessel density at 6 months. Biopsy confirmedGleason 4+3 disease in 1 patient and Gleason 3+4 in 2 others. Testosteronewas discontinued. One of 19 patients taking testosterone and growth hormoneshowed increased PSA at 6 months. Biopsy showed Gleason 3+4.Testosterone and growth hormone were discontinued. None of the studiedgroup developed increased vessel densities after the initial 6-month period.Conclusions—Vessel density sonographic indexing and DCE-MRI analysis correlated well with the biochemical response to testosterone/growthhormone therapies. There was high correlation withhistologic findings. Vascular density increases may signal the need to discontinuehormone replacement therapies. Vascular density stability in theface of rising PSA most likely indicates progression of benign hyperplasiawith increased prostate glandular volume.1540891 Liver Sonography Is Predictive of Liver Steatosis; However,the Severity of Fatty Liver on Sonography Does Not CorrelateWith the Presence of SteatohepatitisRoberta diFlorio,* Robert Harris, David Kim, Eric Goodman,Alex Spinosa, Megan Murphy Radiology, Dartmouth-HitchcockMedical Center, Lebanon, New Hampshire USAObjectives—The spectrum of nonalcoholic fatty live disease(NAFLD) ranges from bland steatosis to cell injury and inflammation(steatohepatitis or nonalcoholic steatohepatitis [NASH]) to fibrosis/cirrhosis.End-stage disease is associated with increased risk of hepatocellularcarcinoma (HCC). Patients with NASH are far more likely to progressto fibrosis than patients with simple steatosis. Currently, liver biopsy isconsidered the gold standard for diagnosis of NAFLD and for differentiatingsteatosis from NASH. However, there is significant variability inliver biopsy due to the error of a small sample size of a heterogeneousprocess. A noninvasive marker of NAFLD would allow detection of globaldisease status and allow stratification of risk for the development of fibrosis.This would permit early drug therapy and allow for surveillance ofcirrhosis complications and HCC. Ultrasound findings that would differentiatesimple steatosis from NASH would be helpful in diagnosing andmonitoring the disease status of NAFLD.S66

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!